165 related articles for article (PubMed ID: 9259588)
1. Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.
Chang JY; Monroe DM; Stafford DW; Brinkhous KM; Roberts HR
J Clin Invest; 1997 Aug; 100(4):886-92. PubMed ID: 9259588
[TBL] [Abstract][Full Text] [Related]
2. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.
Perot E; Enjolras N; Le Quellec S; Indalecio A; Girard J; Negrier C; Dargaud Y
Thromb Res; 2015 May; 135(5):1017-24. PubMed ID: 25795563
[TBL] [Abstract][Full Text] [Related]
3. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
[TBL] [Abstract][Full Text] [Related]
4. Factor IX Fukuoka. Substitution of ASN92 by His in the second epidermal growth factor-like domain results in defective interaction with factors VIIa/X.
Nishimura H; Takeya H; Miyata T; Suehiro K; Okamura T; Niho Y; Iwanaga S
J Biol Chem; 1993 Nov; 268(32):24041-6. PubMed ID: 8226948
[TBL] [Abstract][Full Text] [Related]
5. An Arg/Ser substitution in the second epidermal growth factor-like module of factor IX introduces an O-linked carbohydrate and markedly impairs activation by factor XIa and factor VIIa/Tissue factor and catalytic efficiency of factor IXa.
Hertzberg MS; Facey SL; Hogg PJ
Blood; 1999 Jul; 94(1):156-63. PubMed ID: 10381508
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice.
Toby GG; Liu T; Buyue Y; Zhang X; Bitonti AJ; Pierce GF; Sommer JM; Jiang H; Peters RT
PLoS One; 2016; 11(2):e0148255. PubMed ID: 26840952
[TBL] [Abstract][Full Text] [Related]
7. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
[TBL] [Abstract][Full Text] [Related]
8. First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.
Zhong D; Smith KJ; Birktoft JJ; Bajaj SP
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3574-8. PubMed ID: 8170949
[TBL] [Abstract][Full Text] [Related]
9. Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa.
Larson PJ; Stanfield-Oakley SA; VanDusen WJ; Kasper CK; Smith KJ; Monroe DM; High KA
J Biol Chem; 1996 Feb; 271(7):3869-76. PubMed ID: 8632006
[TBL] [Abstract][Full Text] [Related]
10. Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.
Lu Q; Yang L; Manithody C; Wang X; Rezaie AR
Biochemistry; 2015 Jun; 54(24):3814-21. PubMed ID: 26023895
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127 cells.
Lin SW; Smith KJ; Welsch D; Stafford DW
J Biol Chem; 1990 Jan; 265(1):144-50. PubMed ID: 2294100
[TBL] [Abstract][Full Text] [Related]
12. Identification of functionally important residues of the epidermal growth factor-2 domain of factor IX by alanine-scanning mutagenesis. Residues Asn(89)-Gly(93) are critical for binding factor VIIIa.
Chang YJ; Wu HL; Hamaguchi N; Hsu YC; Lin SW
J Biol Chem; 2002 Jul; 277(28):25393-9. PubMed ID: 11960977
[TBL] [Abstract][Full Text] [Related]
13. Region of factor IXa protease domain that interacts with factor VIIIa: analysis of select hemophilia B mutants.
Bajaj SP
Thromb Haemost; 1999 Aug; 82(2):218-25. PubMed ID: 10605707
[TBL] [Abstract][Full Text] [Related]
14. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
[TBL] [Abstract][Full Text] [Related]
15. Factor IX of the blood coagulation system: a review.
Taran LD
Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
[TBL] [Abstract][Full Text] [Related]
16. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding.
Hertzberg MS; Ben-Tal O; Furie B; Furie BC
J Biol Chem; 1992 Jul; 267(21):14759-66. PubMed ID: 1634519
[TBL] [Abstract][Full Text] [Related]
17. The connecting segment between both epidermal growth factor-like domains in blood coagulation factor IX contributes to stimulation by factor VIIIa and its isolated A2 domain.
Celie PH; Van Stempvoort G; Fribourg C; Schurgers LJ; Lenting PJ; Mertens K
J Biol Chem; 2002 Jun; 277(23):20214-20. PubMed ID: 11925427
[TBL] [Abstract][Full Text] [Related]
18. Baculovirus-mediated expression of the epidermal growth factor-like modules of human factor IX fused to the factor XIIIa transamidation site in fibronectin. Evidence for a direct interaction between the NH2-terminal epidermal growth factor-like module of factor IXa beta and factor X.
Astermark J; Sottile J; Mosher DF; Stenflo J
J Biol Chem; 1994 Feb; 269(5):3690-7. PubMed ID: 7906269
[TBL] [Abstract][Full Text] [Related]
19. The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex.
Wong MY; Gurr JA; Walsh PN
Biochemistry; 1999 Jul; 38(28):8948-60. PubMed ID: 10413468
[TBL] [Abstract][Full Text] [Related]
20. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
